what fuels triple negative breast cancer

Release time ：Nov-08,2024

Triple-negative breast cancer is a type of aggressive cancer characterized by the absence of estrogen receptors, progesterone receptors, and an overabundance of human epidermal growth factor receptor 2 (HER2). This lack of receptor expression means the cancer does not respond to hormone therapies or HER2-targeted treatments, complicating treatment strategies.

Genetic predisposition, such as mutations in the BRCA1 gene, can significantly increase the risk of developing triple-negative breast cancer. Environmental factors including dietary habits, lifestyle choices, and exposure to certain chemicals may also play a role in the disease's onset and progression. Furthermore, research suggests that inflammation and immune system dysfunction could contribute to the development of this form of cancer.

For patients diagnosed with triple-negative breast cancer, it is crucial to adhere to a standardized treatment plan as directed by their healthcare providers. Maintaining a healthy lifestyle, including a balanced diet, regular physical activity, and avoiding tobacco use, can also contribute to better outcomes. Throughout treatment, patients should vigilantly monitor their condition, undergo regular check-ups, and engage in ongoing surveillance to ensure timely adjustments to their therapeutic approach.